Beyond GDF-15, we have previously shown that osteoprotegerin (OPG), OPN, fibroblast growth factor 23 (FGF-23), and TFF3 are important biomarkers for prediction of bleeding in patients with CAD or AF [21, 34, 35]. This evidence concerns the gene FGF23 and coronary artery disorder.